BATS BZX Real-Time Price
As of 10:44am ET
| +0.10 / +0.59%|
The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 33.00, with a high estimate of 41.00 and a low estimate of 25.00. The median estimate represents a +95.04% increase from the last price of 16.92.
The current consensus among 5 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.